These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8855263)

  • 1. p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts.
    Dietrich C; Bartsch T; Schanz F; Oesch F; Wieser RJ
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10815-9. PubMed ID: 8855263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of rheumatoid synoviocyte proliferation by endogenous p53 induction.
    Migita K; Tanaka F; Yamasaki S; Shibatomi K; Ida H; Kawakami A; Aoyagi T; Kawabe Y; Eguchi K
    Clin Exp Immunol; 2001 Nov; 126(2):334-8. PubMed ID: 11703379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor.
    Mikulski SM; Viera A; Deptala A; Darzynkiewicz Z
    Int J Oncol; 1998 Oct; 13(4):633-44. PubMed ID: 9735389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
    Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
    Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
    J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-Jun N-terminal kinase 1 (JNK1) in cell cycle checkpoint activated by the protease inhibitor N-acetyl-leucinyl-leucinyl-norleucinal.
    Tchou WW; Yie TA; Tan TH; Rom WN; Tchou-Wong KM
    Oncogene; 1999 Nov; 18(50):6974-80. PubMed ID: 10597296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction resulting from proteasome inhibition.
    Shinohara K; Tomioka M; Nakano H; Toné S; Ito H; Kawashima S
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):385-8. PubMed ID: 8713062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors.
    Parry GC; Martin T; Felts KA; Cobb RR
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):934-40. PubMed ID: 9633934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis of cell cycle kinetics upon proteasome inhibition.
    Machiels BM; Henfling ME; Gerards WL; Broers JL; Bloemendal H; Ramaekers FC; Schutte B
    Cytometry; 1997 Jul; 28(3):243-52. PubMed ID: 9222110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway.
    Boutillier AL; Kienlen-Campard P; Loeffler JP
    Eur J Neurosci; 1999 Feb; 11(2):441-8. PubMed ID: 10051745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
    Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
    Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
    Choi YH
    Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
    Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
    Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of in vivo proteasome activity in a starfish oocyte using membrane-impermeant substrate.
    Chiba K; Sato E; Hoshi M
    J Biochem; 1997 Aug; 122(2):286-93. PubMed ID: 9378704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
    Mellgren RL
    J Biol Chem; 1997 Nov; 272(47):29899-903. PubMed ID: 9368065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.